Canada markets closed

Alliance Pharma plc (APH.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
Add to watchlist
68.00+0.50 (+0.74%)
At close: 06:03PM BST

Alliance Pharma plc

Avonbridge House
Bath Road
Chippenham SN15 2BB
United Kingdom
44 12 4946 6966

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees285

Key Executives

NameTitlePayExercisedYear Born
Mr. Andrew Timothy FranklinInterim CEO, CFO & Exec. Director417.2kN/A1966
Mr. Peter Jonathan ButterfieldCEO & Exec. Director (Leave of Absence)978.91kN/A1976
Mr. Jeyan Heper (Hons), BACOO & DirectorN/AN/AN/A
Mr. Stephen KidnerChief Scientific Affairs OfficerN/AN/AN/A
Ms. Cora Maeve McCallum C.F.A.Head of Investor Relations & Corp. CommunicationsN/AN/AN/A
Mr. Alex DugganChief Commercial & Corp. Devel. OfficerN/AN/AN/A
Ms. Janice TimberlakeChief People & Infrastructure OfficerN/AN/AN/A
Chris DelafieldGlobal Marketing Head of Kelo-CoteN/AN/AN/A
Rhodri SmithHead of SourcingN/AN/AN/A
Mr. Christodoulos ChrysanthouCompany Sec.N/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.


Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.

Corporate Governance

Alliance Pharma plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.